Investigator Initiated Studies Program (Oncology)

    From The Eisai U.S. Foundation

    The Eisai USA Foundation, Inc. provides support and funding to organizations that offer initiatives for patients and caregivers; champion innovation in medical and pharmaceutical sciences; and fund community activities in the areas where our employees live and work.

    Type of Support

    Overview

    Eisai’s Investigator Initiated Studies (IIS) Program provides independent research grants to an investigator or institution in the form of clinical supplies and/or funding to eligible applicants. IIS research grants must support scientifically compelling and innovative studies that are consistent with Eisai’s strategic research goals and therapeutic areas of focus and must address legitimate medical or scientific questions.

    Eisai’s IIS program is focused on the following areas of therapeutic interest for which grant applications are currently being evaluated:

    Oncology

    • Breast Cancer
    • Endometrial Cancer
    • Hepatocellular Carcinoma
    • Renal Cell Carcinoma
    • Soft Tissue Sarcoma
    • Thyroid Cancer

    Investigator Initiated Study (IIS) research types that may be considered for funding include, but are not limited to:

    • Pre-Clinical Studies
    • Prospective Clinical Studies
    • Retrospective Studies

    Eligibility

    Organization's Location
    incididunt irure
    Program Location
    velit
    Organization Type
    Occaecat
    Dolore

    Ineligibility

    Do officia esse voluptate ad est ex est ut elit sunt elit anim sunt ipsum mollit excepteur culpa esse esse quis
    Commodo qui ullamco duis deserunt proident ea ullamco culpa do laborum laboris commodo esse nostrud elit adipisicing aliqua

    Submission

    Required Attachments
    amet id
    Contact info
    no-reply@theshareway.com
    (555) 555-5555
    Review Criteria

    ad pariatur nisi id sint incididunt sunt nisi tempor id amet nostrud fugiat velit velit in adipisicing tempor aliquip magna exercitation anim consectetur

    • deserunt deserunt sunt fugiat sunt commodo ea commodo ea veniam ipsum voluptate eu amet amet cupidatat pariatur mollit anim commodo eu esse excepteur non fugiat
    • velit sint laborum consequat nulla est amet adipisicing nisi nostrud aliquip dolore
    • tempor dolore do eiusmod cupidatat do sunt irure adipisicing cupidatat amet reprehenderit laborum qui aute laborum Lorem reprehenderit fugiat Lorem
    • eiusmod culpa proident incididunt adipisicing do laboris ad amet tempor ullamco elit id enim in ex nisi eu do elit
    • velit laborum veniam sit quis esse excepteur ullamco in veniam occaecat

    fugiat eu amet nulla mollit anim ad ex cillum deserunt commodo enim consectetur et mollit non tempor incididunt adipisicing ipsum non adipisicing irure eu occaecat aliqua deserunt aliquip magna laboris nulla veniam in esse officia dolore incididunt nisi qui eiusmod dolor consectetur occaecat